← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Glycomira, Llc
Salt Lake City, UT
$11,464,902
Total funding
12
Grants
Funding over time
peak $2.5M · FY2009–24$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,464,902 · 12
By mechanism
R44$6,636,142 · 3
SB1$2,826,053 · 1
R43$1,407,435 · 7
R41$595,272 · 1
Investigators at Glycomira, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$1,530,893
SB1 · FY2021 · DE
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$1,094,718
SB1 · FY2022 · DE
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$999,953
R44 · FY2021 · AI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$976,018
R44 · FY2022 · AI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$841,614
R44 · FY2019 · AI
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$814,843
R44 · FY2013 · DE
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$783,698
R44 · FY2020 · AI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$781,547
R44 · FY2018 · AI
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$685,157
R44 · FY2014 · DE
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$381,446
R44 · FY2017 · DE
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$364,866
R44 · FY2016 · DE
Development of a Diagnostic Test for Eosinophilic Chronic Rhinosinusitis$304,921
R41 · FY2023 · AI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$297,614
R43 · FY2016 · AI
Development of a Diagnostic Test for Eosinophilic Chronic Rhinosinusitis$290,351
R41 · FY2024 · AI
Novel Glycosaminoglycan Ethers for Prevention of Metastasis$210,000
R43 · FY2011 · CA
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$210,000
R43 · FY2011 · DE
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$200,442
SB1 · FY2023 · DE
Novel Glycosaminoglycan Derivatives for Treatment of Bladder Inflammation$200,024
R43 · FY2011 · DK
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$199,997
R43 · FY2014 · DE
Sulfated Polysaccharide Derivatives for the Treatment of Rosacea$149,800
R43 · FY2009 · AR